Internal Medicine, Medical Oncology · York, PA
NPI
1487616595
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1600 6th Ave, Ste 101
York, PA, 17403
Phone (717) 845-7373
Groups this clinician bills Medicare through
Medicare paid, 2024
$823K
47,509 services
Medicare patients, 2024
188
Average age 75
Drug cost, 2024
$2.2M
578 prescriptions
Company payments, 2025
$259
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Surinder P Vohra was code J0897 (injection, denosumab, 1 mg), 7,560 times for 60 patients. In total Surinder P Vohra billed 47,509 services in 63 codes, and Medicare paid $823K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 7,560 | 60 | $20.43 | $154K |
| 99214 Office E&M - Established | Office | 546 | 165 | $99.48 | $54K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 442 | 13 | $0.23 | $99.85 |
| 96375 Injection Administration | Office | 341 | 20 | $12.15 | $4,143 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 186 | 103 | $13.29 | $2,472 |
| 85025 Blood Count | Office | 156 | 22 | $7.61 | $1,187 |
| 96415 Chemotherapy Administration | Office | 140 | 11 | $22.06 | $3,088 |
| 96365 Intravenous Infusion, Hydration | Office | 138 | 15 | $46.91 | $6,474 |
| 96413 Chemotherapy Administration | Office | 127 | 17 | $101.19 | $13K |
| 99215 Office E&M - Established | Office | 120 | 68 | $143.83 | $17K |
| 96372 Injection Administration | Office | 119 | 62 | $11.57 | $1,377 |
| J1200 Injection, diphenhydramine hcl, up to 50 mg | Office | 92 | 17 | $0.65 | $59.42 |
| 99205 Office E&M - New | Office | 24 | 24 | $168.86 | $4,053 |
By year: 2022 $1.1M for 54,353 services; 2023 $864K for 38,510 services; 2024 $823K for 47,509 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 156 | 22 | $7.61 | $1,187 |
Medicare prescription drug claims, 2024
In 2024, the drug Surinder P Vohra prescribed most often to Medicare patients was Hydroxyurea, with 62 prescriptions and refills. In total Surinder P Vohra wrote 578 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 62 | 156 | 13 | $2,006 |
| Jakafi Ruxolitinib Phosphate | 55 | 55 | Under 11 | $707K |
| Prednisone Generic | 34 | 34 | Under 11 | $152 |
| Prolia Denosumab | 33 | 183 | 20 | $56K |
| Ondansetron Odt Ondansetron | 26 | 26 | Under 11 | $123 |
| Exemestane Generic | 25 | 51 | Under 11 | $2,713 |
| Lenalidomide Generic | 20 | 20 | Under 11 | $284K |
| Palonosetron Hcl Generic | 18 | 18 | Under 11 | $3,729 |
| Dexamethasone Sodium Phosphate Generic | 16 | 16 | Under 11 | $46.45 |
| Brukinsa Zanubrutinib | 13 | 13 | Under 11 | $92K |
| Anastrozole Generic | 13 | 24 | Under 11 | $125 |
| Dexamethasone Generic | 13 | 13 | Under 11 | $242 |
| Zenpep Lipase/Protease/Amylase | 12 | 12 | Under 11 | $4,107 |
| Tasigna Nilotinib Hcl | 12 | 12 | Under 11 | $242K |
| Xgeva Denosumab | 12 | 12 | Under 11 | $39K |
Brand drugs: 189 claims; generic drugs: 389 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Surinder P Vohra $259 ($259 in general payments such as food, travel and fees) from 8 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $54.93.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $54.93 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $52.56 |
| Janssen Biotech, Inc. JNJ | 3 | $48.42 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $26.92 |
| Eisai Inc. 4523.T | 1 | $24.23 |
| BeOne Medicines USA, Inc. ONC | 1 | $20.03 |
| Rigel Pharmaceuticals, Inc. RIGL | 1 | $17.11 |
| Daiichi Sankyo Inc. 4568.T | 1 | $14.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.